Karolina Stępień-Hołubczat

BACTEROMIC has been accelerated in the Scope Fluidics Group. The company develops technological projects for medical diagnostics and healthcare. The strategic goal of the Group is to generate profits as a result of sales of independently developed technology projects for global manufacturers of medical devices. The Scope Fluidics Group provides developed projects with financing, access to laboratories and workshops, and crucial administrative facilities and services. BACTEROMIC is the first system to offer full and actionable information for precision antibiotics therapies. BACTEROMIC problems all clinically relevant antibiotics in single test. BACTEROMIC is also the first system to offer automated testing of multiple antibiotic combinations.